Hutch News
Results per Page:
Gaining gastrointestinal GVHD control
Phase III clinical trial on drug therapy to combat graft-vs.-host disease in stem-cell patients shows significant reduction in deaths
For the First Time a Molecular Test Proves to be Effective in Measuring the Extent of Remission After Cancer Treatment and the Potential for Relapse
The molecular test is already saving lives of patients who relapse after bone-marrow or stem-cell transplantation. Researchers now predict that the approach will speed the delivery of promising new therapies to other patients